Deepa Prasad serves as Executive at Design Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Deepa Prasad has executed 2 insider transactions totaling $27.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 29, 2023 involved purchasing 12,000 shares valued at $27.7K.
Deepa Prasad currently holds 23,806 shares of Design Therapeutics, Inc. (DSGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Deepa Prasad has been a net buyer of DSGN stock. They have purchased $27.7K and sold $0 worth of shares.
Deepa Prasad's most recent insider trade was on Aug 29, 2023, when they purchased 12,000 shares at $2.31 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |